FindTrial
Sign In

manufactured by Jaber Pharmaceutical Company) plus Empagliflozin 10 mg tablet (manufactured by Abidi Pharmaceutical Company), once daily for 12 weeks. Intervention 2: Control group: Standard treatment

2 trials

Sponsors

Shahre-kord University of Medical Sciences

Conditions

Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease, unspecifiedPulmonary hypertension secondary to chronic obstructive pulmonary disease. Pulmonary heart disease, unspecified

Phase 2

Effect of Empagliflozin on Pulmonary Arterial Hypertension Secondary to COPD
Active, not recruitingIRCT20250908067192N1
Shahre-kord University of Medical SciencesPulmonary hypertension secondary to chronic obstructive pulmonary disease. Pulmonary heart disease, unspecified
Start: 2025-11-12Target: 72Updated: 2025-10-13
The Effect of Empagliflozin on Spirometric Indices in Patients With Chronic Obstructive Pulmonary Disease
RecruitingIRCT20251127068134N1
Shahre-kord University of Medical SciencesChronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease, unspecified
Start: 2026-01-20Target: 72Updated: 2026-02-02